Clinical Trials on Tyrosinemia Type 2

Total 57747 results

Wellstat Therapeutics

Completed

Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)

Type 2 Diabetes Mellitus

United States
University of Adelaide
Salk Institute for Biological Studies; University of South Australia

Completed

Time RestrIcted Feeding For Improving Diabetes Risk (TRIFFID) (TRIFFID)

Obesity | Type2 Diabetes

Australia
HighTide Biopharma Pty Ltd
Shenzhen HighTide Biopharmaceutical Ltd.

Recruiting

Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

T2DM (Type 2 Diabetes Mellitus)

China
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study of TG103 Injection in Type 2 Diabetes Subjects

Type 2 Diabetes Mellitus

China
Beijing Chao Yang Hospital

Not yet recruiting

Effectiveness of Shared Care Diabetes Management in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

China
Tehran University of Medical Sciences

Completed

Effectiveness of the Farsi Diabetes Self-management Education (FDSME) Program for People With Type 2 Diabetes (FDSME)

Type 2 Diabetes Mellitus
Insulet Corporation

Completed

Omnipod® 5 Automated Insulin Delivery System in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
Daewoong Pharmaceutical Co. LTD.

Completed

The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes. (ENHANCE-M)

T2DM (Type 2 Diabetes Mellitus)

Korea, Republic of
Seoul National University Bundang Hospital
Astellas Pharma Korea, Inc.

Completed

Efficacy of Ipragliflozin Compared With Sitagliptin in Uncontrolled Type 2 Diabetes With Sulfonylurea and Metformin

Type 2 Diabetes Mellitus

Korea, Republic of
Population Health Research Institute
Merck Sharp & Dohme LLC

Completed

Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)

Type 2 Diabetes Mellitus

Canada
Eli Lilly and Company

Completed

A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes

Type 2 Diabetes Mellitus

China, Mexico, Argentina
University Hospital Tuebingen

Withdrawn

Dapagliflozin Effect on Erythropoiesis and Physical Fitness

Type 2 Diabetes Mellitus (T2DM)

Germany
Vinmec Research Institute of Stem Cell and Gene...

Completed

Outcomes of Expanded Autologous Bone Marrow-derived Mesenchymal Stem Cells Therapy in Type II Diabetes (ASD2)

Type 2 Diabetes Mellitus

Vietnam
OPKO Health, Inc.

Completed

Effects and Safety of OPK-88003 Dose Escalation in Type 2 Diabetes Subjects

Type 2 Diabetes Mellitus

United States
East Coast Institute for Research
Valeritas, Inc.; Dallas Diabetes Research Center

Completed

Regular Insulin vs Rapid Insulin Delivered by V-Go

Type 2 Diabetes Mellitus | Type 2 Diabetes

United States
Population Health Research Institute
AstraZeneca

Completed

Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Forxiga

Type 2 Diabetes Mellitus

Canada
Population Health Research Institute
Sanofi

Completed

Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixi (REMIT-iGL)

Type 2 Diabetes Mellitus

Canada
Läkarexpressen AB
Lund University; Region Skane; Region Halland; Västra Götalandsregionen

Completed

Easy Diabetes Treatment Study 1 (EASY-1)

Type 2 Diabetes Mellitus

Sweden
Sanofi

Completed

Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications (SENIOR)

Type 2 Diabetes Mellitus

United States, Australia, Spain, Korea, Republic of, Hungary, Mexico, Italy, Poland, Argentina, Canada, Colombia, France, Germany, Japan, Peru, Romania, Sweden, United Kingdom
Eli Lilly and Company

Completed

A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes (PRONTO-T2D)

Type 2 Diabetes Mellitus

United States, Hungary, Puerto Rico, Spain, Australia, Korea, Republic of, Mexico, Japan, Germany, Russian Federation, Taiwan, Slovakia, Argentina, Czechia, India, Italy
University of Leicester
University Hospitals, Leicester; Loughborough University; Baker Heart and Diabetes...

Completed

The Effects of Reducing Prolonged Sitting Bouts in Individuals at High Risk of or With Type 2 Diabetes (UP FOR 5)

Type 2 Diabetes Mellitus

United Kingdom
Bristol-Myers Squibb

Completed

Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

South Africa, United States, Canada, Puerto Rico, Hungary, Germany, Czechia, Poland, Romania, United Kingdom
Melior Pharmaceuticals
Bukwang Pharmaceutical, Co., Ltd.

Unknown

An Add-on Study of MLR-1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy

Type 2 Diabetes Mellitus

United States
AstraZeneca

Completed

A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin

Type 2 Diabetes Mellitus

United States, Poland, Mexico, Hungary, Spain, Romania, South Africa, Denmark, Czechia, Sweden
Xijing Hospital
Xi'an Central Hospital; First Affiliated Hospital Xi'an Jiaotong University; Shaanxi... and other collaborators

Completed

Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes

Type 2 Diabetes Mellitus

China
University of Guelph
Ontario Ministry of Agriculture, Food and Rural Affairs; Maple Leaf Foods,...

Completed

The Effect of Resistant Starch Bagels on Risk Factors of Type 2 Diabetes and Colorectal Cancer

Type 2 Diabetes Mellitus

Canada
Bispebjerg Hospital
University of Copenhagen; University of Aarhus

Completed

Cut Down on Carbohydrate Usage in the Diet of Type 2 Diabetes (CutDM-iso)

Type 2 Diabetes Mellitus

Denmark
University Hospital, Strasbourg, France
Novartis

Completed

A Prospective, Multicenter, Randomized, Open-label Study of 12 Week Duration to Evaluate the Effect of VILDagliptin Added to Insulin on Glycaemic Control in haemoDIALyzed Patients With Type 2 Diabetes: Probe Analysis of CGM

Haemodialyzed, Type 2 Diabetes

France
Hoffmann-La Roche

Completed

A Study to Investigate in Healthy Volunteers (Part 1) and in Patients With Type 2 Diabetes Mellitus (Part 2) the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of RO6799477

Healthy Volunteer, Type 2 Diabetes

Netherlands
Abbott Diabetes Care

Completed

An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes (REPLACE)

Type 2 Diabetes Mellitus

France, United Kingdom, Germany
NYU Langone Health

Completed

NYULMC CareSmarts Pilot

Diabetes | Type 2 Diabetes (T2D)

United States
Novartis

Completed

Phase 4 Study in the Elderly Patients With T2DM (GLYCEMIA)

Type 2 Diabetes Mellitus | Elderly

France
Sanofi

Completed

Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Germany
Merck Sharp & Dohme LLC

Completed

A Multiple Dose Investigational Drug Study in Patients With Type 2 Diabetes (MK-0941-005)

Type 2 Diabetes Mellitus
UMC Utrecht

Completed

Shared Decision Making Between Patients and GPs in the Treatment of Type 2 Diabetes in Primary Care.

Type 2 Diabetes Mellitus

Netherlands
AstraZeneca

Completed

Phase IV Study With a 36-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin Therapy When Added to the Therapy of Japanese Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin.

Type 2 Diabetes Mellitus

Japan
Karolinska Institutet

Completed

Arginase Inhibition and Microvascular Endothelial Function in Type 2 Diabetes

Type 2 Diabetes Mellitus

Sweden
AstraZeneca
Eli Lilly and Company

Completed

Exenatide Versus Glimepiride in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Czech Republic, Italy, Poland, Spain, United Kingdom, Germany, Hungary, Finland, Mexico, Austria, France, Israel, Switzerland, Ireland
Sanofi

Completed

Assessment of the Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin +/- Metformin

Type 2 Diabetes Mellitus

China, India, Korea, Republic of, Russian Federation
AstraZeneca
Eli Lilly and Company

Completed

A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Netherlands, Canada
AstraZeneca

Completed

A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
AstraZeneca
Eli Lilly and Company

Completed

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin

Type 2 Diabetes Mellitus

United States, Spain, Canada
AstraZeneca
Eli Lilly and Company

Completed

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin

Type 2 Diabetes Mellitus

Korea, Republic of, China, Taiwan, India
AstraZeneca
Eli Lilly and Company

Completed

Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy

Type 2 Diabetes Mellitus

Italy, Poland, Hungary, Mexico, Greece, Australia
University Hospitals, Leicester
Department of Health, United Kingdom

Unknown

A Study to Investigate the Benefits of the Early Detection and Intensive Treatment of Type 2 Diabetes (ADDITION)

Type 2 Diabetes Mellitus

United Kingdom
US Department of Veterans Affairs
American Diabetes Association

Completed

Correlation of Plasma Endothelial Cell Activity With Cardiovascular Events in Patients With Diabetes Mellitus Type 2

Type 2 Diabetes Mellitus

United States
Sanofi

Completed

Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

South Africa, United States, Mexico, United Kingdom
Eli Lilly and Company

Completed

Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy

Type 2 Diabetes Mellitus

United States
University of Copenhagen
Department of Biomedical Sciences; XLab, Center of Healthy Aging

Completed

Influence of Moderate Exercise on Blood Glucose in Type 2 Diabetics and Healthy Controls (DIEGO)

Type 2 Diabetes and Exercise

Denmark
Dexa Medica Group

Completed

Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes Mellitus

Type-2 Diabetes Mellitus

Indonesia

Clinical Trials on Tyrosinemia Type 2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations